| Trial ID: | L1592 |
| Source ID: | NCT00345137
|
| Associated Drug: |
Ng-Monomethyl-L-Arginine (Drug)
|
| Title: |
Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
ADPKD|Glomerulonephritis
|
| Interventions: |
DRUG: Ng-monomethyl-L-arginine (drug)
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Regional Hospital Holstebro
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
75
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE|Primary Purpose:
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-06-27
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00345137
|
